Tezspire by AstraZeneca

A Powerful Launch with a High-Impact Visual Aid

Overview

Working Consulting partnered with AstraZeneca to support the successful launch of Tezspire, a breakthrough treatment for severe asthma. To ensure healthcare professionals (HCPs) fully understood the therapy’s benefits, we developed a high-impact visual aid that transformed complex medical data into a clear, engaging, and persuasive communication tool.

The Challenge

Launching a new pharmaceutical treatment requires precise, evidence-based communication to educate doctors and specialists effectively. AstraZeneca needed a visually compelling and scientifically accurate tool to enhance discussions between HCPs and patients, ensuring Tezspire’s key differentiators stood out in the competitive asthma treatment market.

working-consulting-sanofi-astrazeneca-healh
working-consulting-astrazeneca

Our Solution

We created a state-of-the-art visual aid designed to enhance understanding, retention, and engagement among HCPs. Key elements included:

1. Medical Storytelling & Data Visualization

Simplified complex mechanism of action (MoA) through high-quality graphics.

Clearly presented clinical trial results and real-world efficacy data.

Engaging infographics to highlight Tezspire’s unique benefits over existing treatments.

2. User-Centric Design for HCPs

Structured to facilitate quick, impactful conversations between doctors and patients.

Designed in both digital and print formats for maximum accessibility.

Modular layout allowing for future updates and adaptations.

3. Interactive & Multichannel Approach

QR codes and digital integrations leading to educational videos and deeper resources.

Interactive features to enhance engagement during medical presentations.

Aligned with AstraZeneca’s overall brand strategy and launch campaign.

working-usa-europe
working-graphic
working-consulting-visual-aid-astrazeneca-cliente
work-case-working-consulting-usa
working-consulting-sanofi-astrazeneca-healh

Results & Impact

Successful Tezspire Launch: Strengthened AstraZeneca’s positioning in the severe asthma treatment space.

Improved HCP Engagement: Provided doctors with an effective tool to communicate Tezspire’s benefits to patients.

Stronger Brand Awareness: The visual aid played a key role in driving early adoption of Tezspire.